| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.73B | +114.5% |
| R&D Expense | $455.2M | -14.8% |
| SG&A Expense | $347.1M | +15.4% |
| Operating Income | $866.9M | +386.5% |
| Pre-tax Income | $696.6M | +291.8% |
| Income Tax | $14.0M | +7840.3% |
| Net Income | $682.6M | +287.9% |
| EPS (Basic) | $8.58 | +281.4% |
| EPS (Diluted) | $7.78 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $984.6M | +26.3% |
| Short-term Investments | $960.7M | +166.9% |
| Accounts Receivable | $181.6M | +14.5% |
| Inventory | $79.6M | +243.4% |
| Current Assets | $2.27B | +66.5% |
| Total Assets | $2.90B | +70.0% |
| Current Liabilities | $968.4M | +66.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $711.2M | +760.4% |
| Capital Expenditures | $8.9M | +36.3% |
| Investing Cash Flow | -$862.0M | -2051.0% |
| Financing Cash Flow | $331.1M | +29.4% |
| Free Cash Flow | $702.3M | +715.1% |
| +264.5% |
| Long-term Debt |
| $285.4M |
| +0.0% |
| Total Liabilities | $3.10B | +10.7% |
| Stockholders' Equity | -$205.3M | +81.3% |